Limiting sugar in the first 1000 days of life ‘significantly reduces the diabetes and hypertension risk decades later’
Wes Streeting warned of the burden caused by ‘widening waistbands,’ and called for effective obesity treatments to ease ‘demands on our NHS’
Wegovy could reduce the risk of adverse cardiovascular events by 20%, marking an ‘important step forward’ in tackling the consequences of obesity
New data found an 18% increase in cases of non-diabetic hyperglycaemia or pre-diabetes in 2023 compared to 2022, which is an ‘ever increasing challenge for the NHS’
The warning was issued after people were found to misuse anti-obesity drugs to get ‘beach body’ ready for summer, leading to ‘dangerous consequences’
Tirzepatide, a type-2 diabetes drug has been recommended as a treatment for obesity to help patients 'live longer and healthier lives'
Almost 168,000 people under 40 are living with the condition in the UK, reflecting a ‘troubling growing trend’ of serious health conditions in young people
Excess sugar intake is linked to tooth decay and increases the risk of weight gain which can mean a higher likelihood of living with overweight, obesity, and type 2 diabetes. We, as a population from...
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
